ShangPharma Corp
DelistedCIK 1499470fmd_0EJNNW04QSZNEJ4MJ7XTX3SWC5Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Dec 31, 2011, 3 periods
| Line item | FY2009 | FY2010 | FY2011 |
|---|---|---|---|
| Total revenues | 72 | 90 | 112 |
| Cost of revenue | 48 | 60 | 76 |
| Gross profit | 24 | 30 | 36 |
| Realized investment gains (losses) | – | 0 | – |
| Selling, general and administrative | 14 | 20 | 27 |
| Total operating expenses | 14 | 20 | 26 |
| Operating income | 10 | 10 | 10 |
| Interest expense | – | 0 | 0 |
| Interest and investment income | 0 | 0 | 1 |
| Income before taxes | 11 | 15 | 14 |
| Income tax expense | 2 | 2 | 2 |
| Net income from continuing operations | 10 | 13 | 11 |
| Net income | 10 | 13 | 11 |
| Net income to common shareholders | 7 | 10 | 11 |